FDA Drug Recalls

Recalls / Class III

Class IIID-1179-2017

Product

Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540.

Brand name
Ampicillin
Generic name
Ampicillin Sodium
Active ingredient
Ampicillin Sodium
Route
Intramuscular, Intravenous
NDCs
0781-3400, 0781-3402, 0781-3407, 0781-3404, 0781-3408
FDA application
ANDA061395
Affected lot / code info
Lot: GH8254, Exp 06/19

Why it was recalled

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Recalling firm

Firm
Sandoz Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
100 College Rd W, N/A, Princeton, New Jersey 08540-6604

Distribution

Quantity
13,435 shrink wrap packs
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2017-09-25
FDA classified
2017-09-28
Posted by FDA
2017-10-04
Terminated
2019-04-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1179-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.